289 related articles for article (PubMed ID: 21781241)
1. Novel platelet activation receptor CLEC-2: from discovery to prospects.
Suzuki-Inoue K; Inoue O; Ozaki Y
J Thromb Haemost; 2011 Jul; 9 Suppl 1():44-55. PubMed ID: 21781241
[TBL] [Abstract][Full Text] [Related]
2. Essential in vivo roles of the platelet activation receptor CLEC-2 in tumour metastasis, lymphangiogenesis and thrombus formation.
Suzuki-Inoue K
J Biochem; 2011 Aug; 150(2):127-32. PubMed ID: 21693546
[TBL] [Abstract][Full Text] [Related]
3. GPVI and CLEC-2 in hemostasis and vascular integrity.
Watson SP; Herbert JM; Pollitt AY
J Thromb Haemost; 2010 Jul; 8(7):1456-67. PubMed ID: 20345705
[TBL] [Abstract][Full Text] [Related]
4. [Identification of the novel platelet activation receptor CLEC-2 and Its pathological and physiological roles].
Suzuki Inoue K; Inoue O; Ozaki Y
Rinsho Byori; 2010 Dec; 58(12):1193-202. PubMed ID: 21348239
[TBL] [Abstract][Full Text] [Related]
5. Physiologic and pathophysiologic roles of interaction between C-type lectin-like receptor 2 and podoplanin: partners from in utero to adulthood.
Suzuki-Inoue K; Osada M; Ozaki Y
J Thromb Haemost; 2017 Feb; 15(2):219-229. PubMed ID: 27960039
[TBL] [Abstract][Full Text] [Related]
6. Essential in vivo roles of the C-type lectin receptor CLEC-2: embryonic/neonatal lethality of CLEC-2-deficient mice by blood/lymphatic misconnections and impaired thrombus formation of CLEC-2-deficient platelets.
Suzuki-Inoue K; Inoue O; Ding G; Nishimura S; Hokamura K; Eto K; Kashiwagi H; Tomiyama Y; Yatomi Y; Umemura K; Shin Y; Hirashima M; Ozaki Y
J Biol Chem; 2010 Aug; 285(32):24494-507. PubMed ID: 20525685
[TBL] [Abstract][Full Text] [Related]
7. Thrombomodulation via CLEC-2 targeting.
O'Callaghan CA
Curr Opin Pharmacol; 2009 Apr; 9(2):90-5. PubMed ID: 19091630
[TBL] [Abstract][Full Text] [Related]
8. A novel Syk-dependent mechanism of platelet activation by the C-type lectin receptor CLEC-2.
Suzuki-Inoue K; Fuller GL; García A; Eble JA; Pöhlmann S; Inoue O; Gartner TK; Hughan SC; Pearce AC; Laing GD; Theakston RD; Schweighoffer E; Zitzmann N; Morita T; Tybulewicz VL; Ozaki Y; Watson SP
Blood; 2006 Jan; 107(2):542-9. PubMed ID: 16174766
[TBL] [Abstract][Full Text] [Related]
9. Significant Hypo-Responsiveness to GPVI and CLEC-2 Agonists in Pre-Term and Full-Term Neonatal Platelets and following Immune Thrombocytopenia.
Hardy AT; Palma-Barqueros V; Watson SK; Malcor JD; Eble JA; Gardiner EE; Blanco JE; Guijarro-Campillo R; Delgado JL; Lozano ML; Teruel-Montoya R; Vicente V; Watson SP; Rivera J; Ferrer-Marín F
Thromb Haemost; 2018 Jun; 118(6):1009-1020. PubMed ID: 29695020
[TBL] [Abstract][Full Text] [Related]
10. Syk and Src family kinases regulate C-type lectin receptor 2 (CLEC-2)-mediated clustering of podoplanin and platelet adhesion to lymphatic endothelial cells.
Pollitt AY; Poulter NS; Gitz E; Navarro-Nuñez L; Wang YJ; Hughes CE; Thomas SG; Nieswandt B; Douglas MR; Owen DM; Jackson DG; Dustin ML; Watson SP
J Biol Chem; 2014 Dec; 289(52):35695-710. PubMed ID: 25368330
[TBL] [Abstract][Full Text] [Related]
11. Platelet immunoreceptor tyrosine-based activation motif (ITAM) and hemITAM signaling and vascular integrity in inflammation and development.
Lee RH; Bergmeier W
J Thromb Haemost; 2016 Apr; 14(4):645-54. PubMed ID: 26749528
[TBL] [Abstract][Full Text] [Related]
12. Platelet adhesion to podoplanin under flow is mediated by the receptor CLEC-2 and stabilised by Src/Syk-dependent platelet signalling.
Navarro-Núñez L; Pollitt AY; Lowe K; Latif A; Nash GB; Watson SP
Thromb Haemost; 2015 May; 113(5):1109-20. PubMed ID: 25694214
[TBL] [Abstract][Full Text] [Related]
13. Involvement of the snake toxin receptor CLEC-2, in podoplanin-mediated platelet activation, by cancer cells.
Suzuki-Inoue K; Kato Y; Inoue O; Kaneko MK; Mishima K; Yatomi Y; Yamazaki Y; Narimatsu H; Ozaki Y
J Biol Chem; 2007 Sep; 282(36):25993-6001. PubMed ID: 17616532
[TBL] [Abstract][Full Text] [Related]
14. The physiological and pathophysiological roles of platelet CLEC-2.
Navarro-Núñez L; Langan SA; Nash GB; Watson SP
Thromb Haemost; 2013 Jun; 109(6):991-8. PubMed ID: 23572154
[TBL] [Abstract][Full Text] [Related]
15. Platelet activation receptor CLEC-2 regulates blood/lymphatic vessel separation by inhibiting proliferation, migration, and tube formation of lymphatic endothelial cells.
Osada M; Inoue O; Ding G; Shirai T; Ichise H; Hirayama K; Takano K; Yatomi Y; Hirashima M; Fujii H; Suzuki-Inoue K; Ozaki Y
J Biol Chem; 2012 Jun; 287(26):22241-52. PubMed ID: 22556408
[TBL] [Abstract][Full Text] [Related]
16. Platelets and cancer-associated thrombosis: focusing on the platelet activation receptor CLEC-2 and podoplanin.
Suzuki-Inoue K
Blood; 2019 Nov; 134(22):1912-1918. PubMed ID: 31778548
[TBL] [Abstract][Full Text] [Related]
17. Platelets and cancer-associated thrombosis: focusing on the platelet activation receptor CLEC-2 and podoplanin.
Suzuki-Inoue K
Hematology Am Soc Hematol Educ Program; 2019 Dec; 2019(1):175-181. PubMed ID: 31808911
[TBL] [Abstract][Full Text] [Related]
18. [CLEC-2 induced signalling in blood platelets].
Martyanov AA; Kaneva VN; Panteleev MA; Sveshnikova AN
Biomed Khim; 2018 Sep; 64(5):387-396. PubMed ID: 30378555
[TBL] [Abstract][Full Text] [Related]
19. Targeting of C-type lectin-like receptor 2 or P2Y12 for the prevention of platelet activation by immunotherapeutic CpG oligodeoxynucleotides.
Delierneux C; Donis N; Servais L; Wéra O; Lecut C; Vandereyken M; Musumeci L; Rahmouni S; Schneider J; Eble JA; Lancellotti P; Oury C
J Thromb Haemost; 2017 May; 15(5):983-997. PubMed ID: 28296036
[TBL] [Abstract][Full Text] [Related]
20. The C-type lectin receptors CLEC-2 and Dectin-1, but not DC-SIGN, signal via a novel YXXL-dependent signaling cascade.
Fuller GL; Williams JA; Tomlinson MG; Eble JA; Hanna SL; Pöhlmann S; Suzuki-Inoue K; Ozaki Y; Watson SP; Pearce AC
J Biol Chem; 2007 Apr; 282(17):12397-409. PubMed ID: 17339324
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
